LGALS3 and heart failure: In heart failure patients, a composite “metabolite score” tracked with fibrosis: patients with higher metabolomic scores had higher Gal-3 and worse outcomes, and the metabolite score outperformed Gal-3 in predicting decompensation [12,13].